The trademark application CAIDYA was filed by Clinipace, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 8, 2022, and it was registered by office on December 16, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 35 with following description of goods:
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval
Providing independent review of clinical trials for business purposes
Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management.
The mark was filed in class 41 with Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports.
The mark was filed in class 42 with following description of goods:
Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology
Consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries
Providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy
Product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices
Software as a service (SaaS) services featuring software for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials.
The mark was filed in class 45 with Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research and regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields..